These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 595562)

  • 21. [Pulmonary embolism. Medical and surgical treatment (author's transl)].
    Lagneau P
    J Mal Vasc; 1982; 7(2):161-4. PubMed ID: 7050272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Subconjunctival injection of urokinase in the treatment of diabetic vitreous hemorrhage].
    Chen XL
    Zhonghua Yan Ke Za Zhi; 1983 Jan; 19(1):35-6. PubMed ID: 6406190
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and biological aspects of urokinase therapy].
    Potron G; Droulle C; Nicaise H; Seys A; Leroux B; Morice JC; Gerard J; Robert JF
    Therapie; 1975; 30(5):695-704. PubMed ID: 1221560
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravitreal urokinase in the treatment of vitreous haemorrhage.
    Cleary PE; Davies EW; Shilling JS; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):587-90. PubMed ID: 4534195
    [No Abstract]   [Full Text] [Related]  

  • 25. Total vitreous haemorrhage. A method of treatment.
    Forrester JV; Williamson J
    Trans Ophthalmol Soc U K (1962); 1974; 94(4):992-9. PubMed ID: 4534148
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fibrinolytic therapy of deep vein thrombosis of the leg and pelvis with streptokinase and urokinase].
    Hasler K; Neumann H
    Med Welt; 1983 Oct; 34(43):1225-9. PubMed ID: 6645913
    [No Abstract]   [Full Text] [Related]  

  • 27. A new "wonder" drug to dissolve clots. The results of urokinase therapy in acute myocardial infarction, pulmonary embolism and deep vein thrombosis.
    Mazel MS; Riera R; Levine ER
    Med Trial Tech Q; 1975; 22(1):52-67. PubMed ID: 1165704
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medical treatment of retinal vein thrombosis].
    Algan B
    Bull Soc Belge Ophtalmol; 1982; 201():15-21. PubMed ID: 7187254
    [No Abstract]   [Full Text] [Related]  

  • 29. Potentiation of the thrombolytic efficacy of single-chain urokinase (Pro-urokinase) by heparin.
    Gulba DC; Fischer K; Reil GH; Daniel WG; Lichtlen PR
    Thromb Haemost; 1988 Oct; 60(2):350-1. PubMed ID: 3146150
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravitreal urokinase in the management of vitreous haemorrhage.
    Sellors PJ; Kanski JJ; Watson DM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):591-8. PubMed ID: 4534196
    [No Abstract]   [Full Text] [Related]  

  • 31. [A study on the urokinase treatment in patients with glomerulonephritis and nephrotic syndrome].
    Konishi K; Kato E; Iyori S; Higashi F
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):429-44. PubMed ID: 6750187
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic therapy with fibrinolytic agents and heparin for recalcitrant nonhealing cutaneous ulcer in the antiphospholipid syndrome.
    Gertner E; Lie JT
    J Rheumatol; 1994 Nov; 21(11):2159-61. PubMed ID: 7869328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinolytic treatment of acute respiratory insufficiency (shock lung) after diagnostic amniocentesis with septic shock].
    Heyes H; Jonatha W; Knoche E; Traub E
    Dtsch Med Wochenschr; 1979 Jul; 104(28):1017-8. PubMed ID: 378633
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urokinase in the treatment of retinal venous obliterations: value and limitations].
    Saraux H; Offret H; Offret M
    Bull Mem Soc Fr Ophtalmol; 1978; 90():75-8. PubMed ID: 750022
    [No Abstract]   [Full Text] [Related]  

  • 36. Urokinase or heparin in the management of patients with deep vein thrombosis?
    Kiil J; Carvalho A; Saksø P; Nielsen HO
    Acta Chir Scand; 1981; 147(7):529-32. PubMed ID: 7048826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
    Monastyrskiĭ VA; Ambarova LI
    Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indications for the use of thrombolytics in cases of cerebrovascular thrombosis also treated with hyperbaric oxygenation (2 ATA)].
    Larcan A; Laprevote-Heully MC; Lambert H; Alexandre P; Picard L; Chrisment N
    Therapie; 1977; 32(3):259-70. PubMed ID: 929497
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases.
    Pogliani EM; Bozzani A; Radaelli F; Conte D; Bardella MT; Colombi M; Quatrini M
    Pharmatherapeutica; 1982; 3(4):268-73. PubMed ID: 6755491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrinolytic therapy and anticoagulation. Pediatric experience].
    Hostalot Abás A; Palomeque Rico A; Pastor Durán X
    An Esp Pediatr; 1997 Sep; 47(3):315-8. PubMed ID: 9499287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.